InvestorsHub Logo
Followers 29
Posts 9421
Boards Moderated 0
Alias Born 04/30/2006

Re: Gold Seeker post# 6026

Wednesday, 11/01/2006 1:50:07 PM

Wednesday, November 01, 2006 1:50:07 PM

Post# of 30387
More Lebed:

"Just got off phone with BOCX's CFO.

Abbot Labs (NYSE: ABT) has been begging BOCX to get exclusive rights to their technology but BOCX only gave them semi-exclusive rights.

BOCX believes that through ABT they will only get a 35% share of cancer test market. BOCX would like to get 60-70% share. Therefore, BOCX is negotiating with several other billion dollar companies right now.

Now that RECAF is about to be commercialized, BOCX is going to begin focusing their resources on something so huge it is hard for me to explain. BOCX will be able to use a radiotag in conjunction with the RECAF test to locate exactly where the cancer is and track if it spreads.

He doesn't believe RECAF will be anything less than a $500MM seller because it has already been proven to detect prostate cancer better than the number one cancer marker test the PSA test which has $500MM in annual sales.

BOCX's RECAF is able to detect all cancers including lung and breast which never had cancer marker tests before. Therefore, he believes the potential market for BOCX is in the billions.

There are only five cancer marker tests total being sold today and the inventors of two of these other tests have already joined BOCX and believe that RECAF will become the biggest seller in the market.

I will have a lot more info for you on BOCX later!!! It looks so strong today.

With this national cancer television show featuring BOCX this weekend I am extremely confident we are going to take off this week and explode!!!

-----

My firm Lebed Biz LLC has been compensated by a third-party (Onyx Consulting), $25,000 cash for a one-month BOCX investor relations contract. Never invest into a stock we discuss unless you can afford to lose your entire investment. For our full disclaimer go to: www.lebed.biz/disclaimer.htm

Jonathan Lebed
Lebed.biz
Staff "


my comment. If we don't end up back on the pinks out of this hype, I will be surprised. Take note, he forgot to say "don't buy" with this email. I think he got excited even for a spammer.
If Wittenberg did really give an interview, this is blatent inside information. The company is definitly in bed with Lebed and pink sheets, here we come.



Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.